Characterization of plasmid-mediated quinolone resistance by the qnrS gene in Escherichia coli isolated from healthy chickens and pigs

Veterinarni Medicina

Volumn 54, Issue 10, 2009, Pages 473-482

  Kuo, H C ^a   Chou, C C ^b   Tu, C ^c   Gong, S R ^d   Han, C L ^e   Liao, J W ^b   Chang, Shao Kuang ^a  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b NATIONAL CHUNG HSING UNIVERSITY   (Taiwan)

^c FISHERIES RESEARCH INSTITUTE   (Taiwan)

^d NATIONAL CHIAYI UNIVERSITY   (Taiwan)

^e TRI SERVICE GENERAL HOSPITAL   (Taiwan)

Author keywords

BlaCTX M; Chicken; Escherichia coli; Pig; Qnr gene

Indexed keywords

ANIMALIA; ESCHERICHIA COLI; GALLUS GALLUS; SUIDAE;

EID: 71649092914     PISSN: 03758427     EISSN: None     Source Type: Journal    
DOI: 10.17221/108/2009-VETMED     Document Type: Article

References (50)

1. Altschul S.F., Madden T.L., Schaffer A.A., Zhang J., Zhang Z., Miller W., Lipman D.J. (1997): Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Research, 7, 3389-3402
2. Anonymous (2007): Performance Standards for Antimicrobial Susceptibility Testing: 17th informational supplement. Clinical and Laboratory Standards Institute/NCCLS, Document M100-S17, 27, 182 pp
3. BAPHIQ (The Bureau of Animal and Plant Health Inspection and Quarantine) (2008): Handbook of Animal Drug Management. In: Regulations for Drugs and Medicated Feeds. BAPHIQ Press, Taiwan. p. 1-3-1-1-3-20
4. Cattoir V., Poirel L., Mazel D., Soussy C.J., Nordmann P. (2007a): Vibrio splendidus as the source of plasmid-mediated QnrS-like quinolone resistance determinants. Antimicrobial Agents and Chemotherapy, 51, 2650-2651
5. Cattoir V., Poirel L., Rotimi V., Soussy C.J., Nordmann P. (2007b): Multiplex PCR for detection of plasmidmediated quinolone resistance qnr genes in ESBL-producing enterobacterial isolates. The Journal of Antimicrobial Chemotherapy, 60, 394-397
6. Cavaco L.M., Hansen D.S., Friis-Moller A., Aarestrup F.M., Hasman H., Frimodt-Moller N. (2007): First detection of plasmid-mediated quinolone resistance (qnrA and qnrS) in Escherichia coli strains isolated from humans in Scandinavia. The Journal of Antimicrobial Chemotherapy, 59, 804-805
7. Cavaco L.M., Frimodt-Moller N., Hasman H., Guardabassi L., Nielsen L., Aarestrup F.M. (2008): Prevalence of quinolone resistance mechanisms and associations to minimum inhibtory concentrations in quinolone-resistant Escherichia coli isolated from humans and swine in Denmark. Microbial Drug Resistance, 14, 162-169
8. Cerquetti M., Garcia-Fernandez A., Giufre M., Fortini D., Accogli M., Graziani C., Luzzi I., Caprioli A., Carattoli A. (2009): First report of plasmid-mediated quinolone resistance determinant qnrS1 in an Escherichia coli strain of animal origin in Italy. Antimicrobial Agents and Chemotherapy, 53, 3112-3114
9. Cesaro A., Bettoni R.R., Lascols C., Merens A., Soussy C.J., Cambau E. (2008): Low selection of topoisomerase mutants from strains of Escherichia coli harbouring plasmid-borne qnr genes. The Journal of Antimicrobial Chemotherapy, 61, 1007-1015
10. Everett M.J., Jin Y.F., Ricci V., Piddock L.J. (1996): Contributions of individual mechanisms to fluoroquinolone resistance in 36 Escherichia coli strains isolated from humans and animals. Antimicrobial Agents and Chemotherapy, 40, 2380-2386
11. Ewing W.H. (1986): Edwards and Ewing's Identification of Enterobacteriaceae. 4th ed. Elsevier Press, New York. 181-245
12. Ferrero L., Cameron B., Manse B., Lagneaux D., Crouzet J., Famechon A., Blanche F. (1994): Cloning and primary structure of Staphylococcus aureus DNA topoisomerase IV: a primary target of fluoroquinolones. Molecular Microbiology, 13, 641-653
13. Gay K., Robicsek A., Strahilevitz J., Park C.H., Jacoby G., Barrett T.J., Medalla F., Chiller T.M., Hooper D.C. (2006): Plasmid-mediated quinolone resistance in non-Typhi serotypes of Salmonella enterica. Clinical Infectious Diseases, 43, 297-304
14. Heuer O.E., Jensen V.F., Hammerum A.M. (2005): Antimicrobial drug consumption in companion animals. Emerging Infectious Disease, 11, 344-345
15. Hopkins K.L., Davies R.H., Threlfall E.J. (2005): Mechanisms of quinolone resistance in Escherichia coli and Salmonella: recent developments. International Journal of Antimicrobial Agents, 25, 358-373
16. Jacoby G.A., Chow N., Waites K.B. (2003): Prevalence of plasmid-mediated quinolone resistance. Antimicrobial Agents and Chemotherapy, 47, 559-562
17. Jacoby G.A., Walsh K.E., Mills D.M., Walker V.J., Oh H., Robicsek A., Hooper D.C. (2006): qnrB, another plasmid-mediated gene for quinolone resistance. Antimicrobial Agents and Chemotherapy, 50, 1178-1182
18. Jiang Y., Zhou Z., Qian Y., Wei Z., Yu Y., Hu S., Li L. (2008): Plasmid-mediated quinolone resistance determinants qnr and aac(6')-ib-cr in extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae in China. The Journal of Antimicrobial Chemotherapy, 61, 1003-1006
19. Jorgensen C.J., Cavaco L.M., Hasman H., Emborg H.D., Guardabassi L. (2007): Occurrence of CTX-M-1-producing Escherichia coli in pigs treated with ceftiofur. The Journal of Antimicrobial Chemotherapy, 59, 1040-1042
20. Kehrenberg C., Friederichs S., de Jong A., Michael G.B., Schwarz S. (2006): Identification of the plasmid-borne quinolone resistance gene qnrS in Salmonella enterica serovar Infantis. The Journal of Antimicrobial Chemotherapy, 58, 18-22
21. Kehrenberg C., de Jong A., Friederichs S., Cloeckaert A., Schwarz S. (2007): Molecular mechanisms of decreased susceptibility to fluoroquinolones in avian Salmonella serovars and their mutants selected during the determination of mutant prevention concentrations. The Journal of Antimicrobial Chemotherapy, 59, 886-892
22. Kehrenberg C., Friederichs S., de Jong A., Schwarz S. (2008): Novel variant of the qnrB gene, qnrB12, in Citrobacter werkmanii. Antimicrobial Agents and Chemotherapy, 52, 1206-1207
23. Kumagai Y., Kato J.I., Hoshino K., Akasaka T., Sato K., Ikeda H. (1996): Quinolone-resistant mutants of Escherichia coli DNA topoisomerase IV parC gene. Antimicrobial Agents and Chemotherapy, 40, 710-714
24. Lapierre L., Cornejo J., Borie C., Toro C., San Martin B. (2008): Genetic characterization of antibiotic resistance genes linked to class 1 and class 2 integrons in commensal strains of Escherichia coli isolated from poultry and swine. Microbial Drug Resistance, 14, 265-272
25. Lascols C., Robert J., Cattoir V., Bebear C., Cavallo J.D., Podglajen I., Ploy M.C., Bonnet R., Soussy C.J., Cambau E. (2007): Type II topoisomerase mutations in clinical isolates of Enterobacter cloacae and other enterobacterial species harbouring the qnrA gene. International Journal of Antimicrobial Agents, 29, 402-409
26. Lavigne J.P., Marchandin H., Delmas J., Bouziges N., Lecaillon E., Cavalie L., Jean-Pierre H., Bonnet R., Sotto A. (2006): qnrA in CTX-M-producing Escherichia coli isolates from France. Antimicrobial Agents and Chemotherapy, 50, 4224-4228
27. Ma J., Zeng Z., Chen Z., Xu X., Wang X., Deng Y., Lu D., Huang L., Zhang Y., Liu J., Wang M. (2009): High prevalence of plasmid-mediated quinolone resistance determinants qnr, aac(6')-Ib-cr, and qepA among ceftiofur-resistant Enterobacteriaceae isolates from companion and food-producing animals. Antimicrobial Agents and Chemotherapy, 53, 519-524
28. Mammeri H., Van De Loo M., Poirel L., Martinez-Martinez L., Nordmann P. (2005): Emergence of plasmidmediated quinolone resistance in Escherichia coli in Europe. Antimicrobial Agents and Chemotherapy, 49, 71-76
29. Martinez-Martinez L., Pascual A., Jacoby G.A. (1998): Quinolone resistance from a transferable plasmid. The Lancet, 351, 797-799
30. Mazzariol A., Tokue Y., Kanegawa T.M., Cornaglia G., Nikaido H. (2000): High-level fluoroquinolone-resistant clinical isolates of Escherichia coli overproduce multidrug efflux protein AcrA. Antimicrobial Agents and Chemotherapy, 44, 3441-3443
31. Nordmann P., Poirel L. (2005): Emergence of plasmidmediated resistance to quinolones in Enterobacteriaceae. The Journal of Antimicrobial Chemotherapy, 56, 463-469
32. Park C.H., Robicsek A., Jacoby G.A., Sahm D., Hooper D. C. (2006): Prevalence in the United States of aac (6')-Ibcr encoding a ciprofloxacin-modifying enzyme. Antimicrobial Agents and Chemotherapy, 50, 3953-3955
33. Poirel L., Liard A., Rodriguez-Martinez J.M., Nordmann P. (2005a): Vibrionaceae as a possible source of Qnrlike quinolone resistance determinants. The Journal of Antimicrobial Chemotherapy, 56, 1118-1121
34. Poirel L., Rodriguez-Martinez J.M., Mammeri H., Liard A., Nordmann P. (2005b): Origin of plasmid-mediated quinolone resistance determinant QnrA. Antimicrobial Agents and Chemotherapy, 49, 3523-3525
35. Rajic A., Reid-Smith R., Deckert A.E., Dewey C.E., McEwen S.A. (2006): Reported antibiotic use in 90 swine farms in Alberta. The Canadian Veterinary Journal, 47, 446-452
36. Robicsek A., Strahilevitz J., Jacoby G.A., Macielag M., Abbanat D., Park C.H., Bush K., Hooper D.C. (2006a): Fluoroquinolone-modifying enzyme: a new adaptation of a common aminoglycoside acetyltransferase. Nature Medicine, 12, 83-88
37. Robicsek A., Strahilevitz J., Sahm D.F., Jacoby G.A., Hooper D.C. (2006b): qnr prevalence in ceftazidimeresistant Enterobacteriaceae isolates from the United States. Antimicrobial Agents and Chemotherapy, 50, 2872-2874
38. Sambrook J., Fritsch E.F., Maniatis T. (1989): Molecular Cloning: A Laboratory Manual. 2nd ed. Cold Spring Harbor Laboratory Press, New York
39. Tolmasky M.E., Roberts M., Woloj M., Crosa J.H. (1986): Molecular cloning of amikacin resistance determinants from a Klebsiella pneumoniae plasmid. Antimicrobial Agents and Chemotherapy, 30, 315-320
40. Thompson J.D., Higgins D.G., Gibson T.J. (1994): CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Research, 22, 4673-4680
41. Tran J.H., Jacoby G.A. (2002): Mechanism of plasmidmediated quinolone resistance. Proceedings of the National Academy of Sciences of the United States of America, 99, 5638-5642
42. Tran J.H., Jacoby G.A., Hooper D.C. (2005): Interaction of the plasmid-encoded quinolone resistance protein QnrA with Escherichia coli topoisomerase IV. Antimicrobial Agents and Chemotherapy, 49, 3050-3052
43. Van den Bogaard A.E., Stobberingh E.E. (1999): Antibiotic usage in animals: impact on bacterial resistance and public health. Drugs, 58, 589-607
44. Vakulenko S. B., Mobashery S. (2003): Versatility of aminoglycosides and prospects for their future. Clinical Microbiology Reviews, 16, 430-450
45. Wu J.J., Ko W.C., Tsai S.H., Yan J.J. (2007): Prevalence of plasmid-mediated quinolone resistance determinants QnrA, QnrB, and QnrS among clinical isolates of Enterobacter cloacae in a Taiwanese hospital. Antimicrobial Agents and Chemotherapy, 51, 1223-1227
46. Wu J.J., Ko W.C., Wu H.M., Yan J.J. (2008): Prevalence of Qnr determinants among bloodstream isolates of Escherichia coli and Klebsiella pneumoniae in a Taiwanese Hospital, 1999-2005. The Journal of Antimicrobial Chemotherapy, 61, 1234-1239
47. Yamane K., Wachino J.I., Suzuki S., Kimura K., Shibata N., Kato H., Shibayama K., Konda T., Arakawa Y. (2007): New plasmid-mediated fluoroquinolone efflux pump, QepA, found in an Escherichia coli clinical isolate. Antimicrobial Agents and Chemotherapy, 51, 3354-3360
48. Yamane K., Wachino J.I., Suzuki S., Arakawa Y. (2008): Plasmid-mediated qepA gene among Escherichia coli clinical isolates, Japan. Antimicrobial Agents and Chemotherapy, 52, 1564-1566
49. Yang H., Chen H., Yang Q., Chen M., Wang H. (2008): High prevalence of plasmid-mediated quinolone resistance genes qnr and aac(6')-Ib-cr in clinical isolates of Enterobacteriaceae from nine teaching hospitals in China. Antimicrobial Agents and Chemotherapy, 52, 4268-4273
50. Yue L., Jiang H.X., Liao X.P., Liu J.H., Li S.J., Chen X.Y., Chen C.X., Lu, D.H., Liu Y.H. (2008): Prevalence of plasmid-mediated quinolone resistance qnr genes in poultry and swine clinical isolates of Escherichia coli. Veterinary Microbiology, 132, 414-420